13 November 2017 - All resubmissions that are filed by manufacturers on or after 2 January 2018 will be subject to an application fee.
A schedule B fee will apply for a resubmission based on new clinical information with or without new cost information and a schedule D fee will apply for a resubmission based only on new cost information.